Numerous types of cancer have been shown to be associated with either ischemic or
hemorrhagic stroke. In this review, the epidemiology and pathophysiology of stroke in …

Advances in hematopoietic cell transplantation (HCT) technology and supportive care
techniques have led to improvements in long-term survival after HCT. Emerging indications …

Chronic graft-versus-host disease (GVHD) can be associated with significant morbidity, in
part because of nonreversible fibrosis, which impacts physical functioning (eye, skin, lung …

In recent years, clinical trials with stem cells have taken the emerging field in many new
directions. While numerous teams continue to refine and expand the role of bone marrow …

As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications
and international access improves, the number of HCTs performed annually continues to …

Alloreactive and autoimmune responses after allogeneic hematopoietic cell transplantation
can occur in nonclassical chronic graft-versus-host disease (chronic GVHD) tissues and …

Neuroinflammation is a recognized complication of immunotherapeutic approaches such as
immune checkpoint inhibitor treatment, chimeric antigen receptor therapy, and graft versus …

Neurologic complications after hematopoietic stem cell transplantation are frequently life-
threatening, and their clinical management can be highly challenging. A wide spectrum of …

Most patients with multiple myeloma (MM) suffer from chronic pain at every stage of the
natural disease process. This review focuses on the most common causes of chronic pain in …

Cancer survivorship represents a growing clinical challenge for pain clinicians. The
population of cancer survivors is rapidly expanding and many of these patients experience …